share_log

Truist Securities Maintains Hold on Inari Medical, Lowers Price Target to $52

Truist Securities Maintains Hold on Inari Medical, Lowers Price Target to $52

Truist Securities继续持有Inari Medical,将目标股价下调至52美元
Moomoo 24/7 ·  03/22 09:08

Truist Securities analyst Richard Newitter maintains Inari Medical (NASDAQ:NARI) with a Hold and lowers the price target from $61 to $52.

Truist Securities分析师理查德·纽特维持伊纳里医疗(纳斯达克股票代码:NARI)的持仓并将目标股价从61美元下调至52美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发